Literature DB >> 9460994

A regulatory role for porphobilinogen deaminase (PBGD) in delta-aminolaevulinic acid (delta-ALA)-induced photosensitization?

S L Gibson1, D J Cupriks, J J Havens, M L Nguyen, R Hilf.   

Abstract

As an initial approach to optimize delta-aminolaevulinic acid (delta-ALA)-induced photosensitization of tumours, we examined the response of three enzymes of the haem biosynthetic pathway: delta-ALA dehydratase, porphobilinogen deaminase (PBGD) and ferrochelatase. Only PBGD activity displayed a time- and dose-related increase in tumours after intravenous administration of 300 mg kg(-1) delta-ALA. The time course for porphyrin fluorescence changes, reflecting increased production of the penultimate porphyrin, protoporphyrin IX (PPIX), showed a similar pattern to PBGD. This apparent correlation between PBGD activity and porphyrin fluorescence was also observed in four cultured tumour cell lines exposed to 0.1-2.0 mM delta-ALA in vitro. The increase in PBGD activity and PPIX fluorescence was prevented by the protein synthesis inhibitor cycloheximide. As the apparent Km for PBGD was similar before and after delta-ALA, the increase in PBGD activity was attributed to induction of enzyme de novo. These observations of an associated response of PBGD and PPIX imply that PBGD may be a rate-limiting determinant for the efficacy of delta-ALA-induced photosensitization when used in photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9460994      PMCID: PMC2151216          DOI: 10.1038/bjc.1998.39

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

Review 1.  Photodynamic therapy to scientists and clinicians--one world or two?

Authors:  S G Bown
Journal:  J Photochem Photobiol B       Date:  1990-06       Impact factor: 6.252

Review 2.  Heme production in animal tissues: the regulation of biogenesis of delta-aminolevulinate synthase.

Authors:  I Z Ades
Journal:  Int J Biochem       Date:  1990

3.  Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus.

Authors:  B Overholt; M Panjehpour; E Tefftellar; M Rose
Journal:  Gastrointest Endosc       Date:  1993 Jan-Feb       Impact factor: 9.427

4.  Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid.

Authors:  W E Grant; C Hopper; A J MacRobert; P M Speight; S G Bown
Journal:  Lancet       Date:  1993-07-17       Impact factor: 79.321

5.  Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats.

Authors:  R Van Hillegersberg; J W Van den Berg; W J Kort; O T Terpstra; J H Wilson
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

6.  Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract.

Authors:  C S Loh; D Vernon; A J MacRobert; J Bedwell; S G Bown; S B Brown
Journal:  J Photochem Photobiol B       Date:  1993-09       Impact factor: 6.252

7.  Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation.

Authors:  N Schoenfeld; R Mamet; Y Nordenberg; M Shafran; T Babushkin; Z Malik
Journal:  Int J Cancer       Date:  1994-01-02       Impact factor: 7.396

8.  Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice.

Authors:  S L Gibson; T H Foster; R H Feins; R F Raubertas; M A Fallon; R Hilf
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

9.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.

Authors:  F Cairnduff; M R Stringer; E J Hudson; D V Ash; S B Brown
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

10.  In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster.

Authors:  C Abels; P Heil; M Dellian; G E Kuhnle; R Baumgartner; A E Goetz
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more
  18 in total

1.  Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.

Authors:  Sanjay Anand; Clara Wilson; Tayyaba Hasan; Edward V Maytin
Journal:  Cancer Res       Date:  2011-08-01       Impact factor: 12.701

2.  Review of Neurosurgical Fluorescence Imaging Methodologies.

Authors:  Brian W Pogue; Summer Gibbs-Strauss; Pablo A Valdés; Kimberley Samkoe; David W Roberts; Keith D Paulsen
Journal:  IEEE J Sel Top Quantum Electron       Date:  2010-05       Impact factor: 4.544

Review 3.  Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives.

Authors:  F S De Rosa; M V Bentley
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

4.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-12       Impact factor: 3.631

Review 5.  Recent advances in photodynamic diagnosis of gastric cancer using 5-aminolevulinic acid.

Authors:  Noriaki Koizumi; Yoshinori Harada; Takeo Minamikawa; Hideo Tanaka; Eigo Otsuji; Tetsuro Takamatsu
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

6.  Massive apoptotic cell death of human glioma cells via a mitochondrial pathway following 5-aminolevulinic acid-mediated photodynamic therapy.

Authors:  Hiroto Inoue; Yoshinaga Kajimoto; Masa-Aki Shibata; Norio Miyoshi; Naoko Ogawa; Shin-Ichi Miyatake; Yoshinori Otsuki; Toshihiko Kuroiwa
Journal:  J Neurooncol       Date:  2007-01-24       Impact factor: 4.506

7.  Hypoxia significantly reduces aminolaevulinic acid-induced protoporphyrin IX synthesis in EMT6 cells.

Authors:  I Georgakoudi; P C Keng; T H Foster
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Review of photodynamic therapy in actinic keratosis and basal cell carcinoma.

Authors:  Marica B Ericson; Ann-Marie Wennberg; Olle Larkö
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

9.  Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma.

Authors:  D Ickowicz Schwartz; Y Gozlan; L Greenbaum; T Babushkina; D J Katcoff; Z Malik
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

10.  Mechanistic studies on delta-aminolevulinic acid uptake and efflux in a mammary adenocarcinoma cell line.

Authors:  S Correa García; A Casas; C Perotti; A Batlle; M Bermúdez Moretti
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.